HWM
TGTX icon

Hemington Wealth Management’s TG Therapeutics TGTX Stock Holding History

Hemington Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Hold
3
– – ﹤0.01% 1723
2025
Q2 		$0 Hold
3
– – ﹤0.01% 1711
2025
Q1 		$0 Sell
3
-5
-63% -$168 ﹤0.01% 1749
2024
Q4 		$0 Buy
8
+2
+33% +$57 ﹤0.01% 1782
2024
Q3 		$0 Buy
+6
New +$131 ﹤0.01% 1739

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hemington Wealth Management's TGTX Position: Q3 2025 in Review

Hemington Wealth Management held its TG Therapeutics (TGTX) position steady in Q3 2025 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

Hemington Wealth Management first reported a position in TGTX in Q3 2024 and has held it in 5 quarters since. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Hemington Wealth Management held 3 shares of TG Therapeutics worth $0 as of Q3 2025.
  • Hemington Wealth Management left its TG Therapeutics share count unchanged in Q3 2025.
  • TG Therapeutics made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1723 holding.
  • Hemington Wealth Management first reported a position in TG Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.